Omeprazole
- Product NDC
- 59651-001
- 11-digit product format
- 596510001
- Labeler code
- 59651
- Product ID
- 59651-001_4cc78adf-d6a3-47b6-bc25-9d3f28d2a27a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Omeprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA203270
- Marketing category
- ANDA
- Marketing start
- 2015-08-19
- Substance
- OMEPRAZOLE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Omeprazole
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OMEPRAZOLE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KG60484QX9 |
| Rxcui | 198051, 199119, 200329 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-001-01 | Omeprazole | 100 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 100 | | 19 |
| 59651-001-03 | Omeprazole | 3 in 1 CARTON | CAPSULE, DELAYED RELEASE | 3 | | 19 |
| 59651-001-10 | Omeprazole | 10 in 1 BLISTER PACK | CAPSULE, DELAYED RELEASE | 10 | | 19 |
| 59651-001-30 | Omeprazole | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 19 |
| 59651-001-78 | Omeprazole | 10 in 1 CARTON | CAPSULE, DELAYED RELEASE | 10 | | 19 |
| 59651-001-99 | Omeprazole | 1000 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 1000 | | 19 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| OMEPRAZOLE | ACTIVE INGREDIENT | KG60484QX9 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| OMEPRAZOLE | ACTIVE MOIETY | KG60484QX9 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INACTIVE INGREDIENT | 94255I6E2T | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-001 | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AUROBINDO PHARMA LIMITED] | 19 | Current NDC, Legacy NDC, 6 package rows | 20240618_934601b6-fbba-43c4-a8ef-7a7dfe9f9a51.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59651-001-01 | 59651000101 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-001-01) | | 2015-08-19 | 0000-00-00 | No | No | Current |
| 59651-001-03 | 59651000103 | 3 BLISTER PACK in 1 CARTON (59651-001-03) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (59651-001-10) | 3 blister pack | 2015-08-19 | 0000-00-00 | No | No | Current |
| 59651-001-10 | 59651000110 | 10 in 1 BLISTER PACK | | | | | | Historical |
| 59651-001-30 | 59651000130 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-001-30) | | 2015-08-19 | 0000-00-00 | No | No | Current |
| 59651-001-78 | 59651000178 | 10 BLISTER PACK in 1 CARTON (59651-001-78) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (59651-001-10) | 10 blister pack | 2015-08-19 | 0000-00-00 | No | No | Current |
| 59651-001-99 | 59651000199 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-001-99) | | 2015-08-19 | 0000-00-00 | No | No | Current |